A detailed history of Caisse De Depot Et Placement Du Quebec transactions in Pfizer Inc stock. As of the latest transaction made, Caisse De Depot Et Placement Du Quebec holds 11,433,418 shares of PFE stock, worth $320 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares
11,433,418
Previous 13,450,174 14.99%
Holding current value
$320 Million
Previous $387 Million 18.06%
% of portfolio
0.78%
Previous 1.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $52.2 Million - $60 Million
-2,016,756 Reduced 14.99%
11,433,418 $317 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $48.4 Million - $62.9 Million
-1,854,116 Reduced 12.12%
13,450,174 $387 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $109 Million - $127 Million
-3,385,662 Reduced 18.11%
15,304,290 $508 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $84.8 Million - $98.2 Million
2,348,735 Added 14.37%
18,689,952 $686 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $8.21 Million - $10.7 Million
208,539 Added 1.29%
16,341,217 $667 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $19.5 Million - $25.4 Million
466,641 Added 2.98%
16,132,678 $827 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $64.5 Million - $78.8 Million
-1,474,491 Reduced 8.6%
15,666,037 $686 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $143 Million - $170 Million
3,083,682 Added 21.94%
17,140,528 $899 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $92.2 Million - $114 Million
2,015,104 Added 16.73%
14,056,846 $728 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $83.8 Million - $124 Million
2,028,788 Added 20.26%
12,041,742 $711 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $324 Million - $416 Million
8,257,100 Added 470.26%
10,012,954 $431 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $26.9 Million - $30.5 Million
-749,344 Reduced 29.91%
1,755,854 $68.8 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $2.57 Million - $2.9 Million
-76,689 Reduced 2.97%
2,505,198 $90.8 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $31.1 Million - $39.6 Million
930,110 Added 56.31%
2,581,887 $95 Million
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $6.81 Million - $7.99 Million
214,600 Added 14.93%
1,651,777 $60.6 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $14.9 Million - $18.1 Million
-495,100 Reduced 25.62%
1,437,177 $47 Million
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $994,704 - $1.42 Million
36,800 Added 1.94%
1,932,277 $63.1 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $1.5 Million - $1.7 Million
45,550 Added 2.46%
1,895,477 $74.3 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $21 Million - $27.3 Million
647,389 Added 53.84%
1,849,927 $66.5 Million
Q2 2019

Aug 09, 2019

SELL
$36.98 - $41.52 $34.5 Million - $38.7 Million
-932,100 Reduced 43.67%
1,202,538 $52.1 Million
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $39 Million - $42.8 Million
-1,038,800 Reduced 32.73%
2,134,638 $90.7 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $27.8 Million - $31.7 Million
722,600 Added 29.48%
3,173,438 $139 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $27.4 Million - $33.3 Million
-795,400 Reduced 24.5%
2,450,838 $108 Million
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $2.58 Million - $2.75 Million
-78,300 Reduced 2.36%
3,246,238 $118 Million
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $81 Million - $94 Million
-2,538,400 Reduced 43.3%
3,324,538 $118 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $20 Million - $21.2 Million
-602,000 Reduced 9.31%
5,862,938 $212 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $200 Million - $221 Million
6,464,938
6,464,938 $232 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Caisse De Depot Et Placement Du Quebec Portfolio

Follow Caisse De Depot Et Placement Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.